ArticleJournal of managed care & specialty pharmacy2024

Utilization and patient characteristics for the trastuzumab reference and biosimilars, and other human epidermal growth factor receptor 2 inhibitors in the United States.

Xiaodan Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.